Literature DB >> 23335080

Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts.

Angela Lee1, Yu Qiao, Galina Grigoriev, Janice Chen, Kyung-Hyun Park-Min, Sung Ho Park, Lionel B Ivashkiv, George D Kalliolias.   

Abstract

OBJECTIVE: The nonresolving character of synovial inflammation in rheumatoid arthritis (RA) is a conundrum. To identify the contribution of fibroblast-like synoviocytes (FLS) to the perpetuation of synovitis, we investigated the molecular mechanisms that govern the tumor necrosis factor α (TNFα)-driven inflammatory program in human FLS.
METHODS: FLS obtained from the synovial tissues of patients with RA or osteoarthritis were stimulated with TNFα and assayed for gene expression and cytokine production by real-time quantitative reverse transcription-polymerase chain reaction analysis and enzyme-linked immunosorbent assay. NF-κB signaling was evaluated by Western blotting. Histone acetylation, chromatin accessibility, and NF-κB p65 and RNA polymerase II (Pol II) occupancy at the interleukin-6 (IL-6) promoter were measured by chromatin immunoprecipitation and restriction enzyme accessibility assays.
RESULTS: In FLS, TNFα induced prolonged transcription of messenger RNA (mRNA) for IL-6 and progressive accumulation of IL-6 protein over 4 days. Similarly, induction of mRNA for CXCL8/IL-8, CCL5/RANTES, matrix metalloproteinase 1 (MMP-1), and MMP-3 after TNFα stimulation was sustained for several days. This contrasted with the macrophage response to TNFα, which characteristically involved a transient increase in the expression of proinflammatory genes. In FLS, TNFα induced prolonged activation of NF-κB signaling and sustained transcriptional activity, as indicated by increased histone acetylation, chromatin accessibility, and p65 and Pol II occupancy at the IL-6 promoter. Furthermore, FLS expressed low levels of the feedback inhibitors A20-binding inhibitor of NF-κB activation 3 (ABIN-3), IL-1 receptor-associated kinase M (IRAK-M), suppressor of cytokine signaling 3 (SOCS-3), and activating transcription factor 3 (ATF-3), which terminate inflammatory responses in macrophages.
CONCLUSION: TNFα signaling is not effectively terminated in FLS, which leads to an uncontrolled inflammatory response. The results suggest that prolonged and sustained inflammatory responses by FLS in response to synovial TNFα contribute to the persistence of synovial inflammation in RA.
Copyright © 2013 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23335080      PMCID: PMC3618592          DOI: 10.1002/art.37853

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  50 in total

Review 1.  Role of nuclear factor kappaB in synovial inflammation.

Authors:  Ulf Müller-Ladner; Renate E Gay; Steffen Gay
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

Review 2.  How important are T cells in chronic rheumatoid synovitis?

Authors:  G S Firestein; N J Zvaifler
Journal:  Arthritis Rheum       Date:  1990-06

3.  Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.

Authors:  P A Guerne; B L Zuraw; J H Vaughan; D A Carson; M Lotz
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

4.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.

Authors:  R Altman; E Asch; D Bloch; G Bole; D Borenstein; K Brandt; W Christy; T D Cooke; R Greenwald; M Hochberg
Journal:  Arthritis Rheum       Date:  1986-08

5.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

6.  The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon.

Authors:  Sanna Rosengren; Maripat Corr; Gary S Firestein; David L Boyle
Journal:  Ann Rheum Dis       Date:  2011-11-25       Impact factor: 19.103

7.  CD40 engagement on synovial fibroblast up-regulates production of vascular endothelial growth factor.

Authors:  C S Cho; M L Cho; S Y Min; W U Kim; D J Min; S S Lee; S H Park; J Choe; H Y Kim
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

8.  How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease.

Authors:  Isao Matsumoto; Mariana Maccioni; David M Lee; Madelon Maurice; Barry Simmons; Michael Brenner; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2002-03-18       Impact factor: 25.606

9.  Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns.

Authors:  Greg Parsonage; Francesco Falciani; Angela Burman; Andrew Filer; Ewan Ross; Margarita Bofill; Stuart Martin; Mike Salmon; Christopher D Buckley
Journal:  Thromb Haemost       Date:  2003-10       Impact factor: 5.249

Review 10.  Evolving concepts of rheumatoid arthritis.

Authors:  Gary S Firestein
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

View more
  49 in total

Review 1.  TNF biology, pathogenic mechanisms and emerging therapeutic strategies.

Authors:  George D Kalliolias; Lionel B Ivashkiv
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

2.  DNA methylation analysis of SOCS1, SOCS3, and LINE-1 in microdissected gingival tissue.

Authors:  Denise C Andia; Aline C Planello; Danielle Portinho; Rodrigo A da Silva; Cristiane R Salmon; Enilson A Sallum; Francisco H Nociti Junior; Ana P de Souza
Journal:  Clin Oral Investig       Date:  2015-04-07       Impact factor: 3.573

3.  Rheumatoid arthritis: TAK-ing the road to suppress inflammation in synovial fibroblasts.

Authors:  Mojca Frank-Bertoncelj; Steffen Gay
Journal:  Nat Rev Rheumatol       Date:  2017-01-12       Impact factor: 20.543

4.  Adenosine monophosphate-activated protein kinase activation and suppression of inflammatory response by cell stretching in rabbit synovial fibroblasts.

Authors:  Wanlop Kunanusornchai; Chatchai Muanprasat; Varanuj Chatsudthipong
Journal:  Mol Cell Biochem       Date:  2016-09-30       Impact factor: 3.396

Review 5.  Selected cytokine pathways in rheumatoid arthritis.

Authors:  Mélissa Noack; Pierre Miossec
Journal:  Semin Immunopathol       Date:  2017-02-17       Impact factor: 9.623

Review 6.  Toll-Like Receptor Pathways in Autoimmune Diseases.

Authors:  Ji-Qing Chen; Peter Szodoray; Margit Zeher
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 7.  New insights into the epigenetics of inflammatory rheumatic diseases.

Authors:  Esteban Ballestar; Tianlu Li
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

8.  Genetic polymorphism directs IL-6 expression in fibroblasts but not selected other cell types.

Authors:  Erika H Noss; Hung N Nguyen; Sook Kyung Chang; Gerald F M Watts; Michael B Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-17       Impact factor: 11.205

9.  Interleukin-34 in rheumatoid arthritis: potential role in clinical therapy.

Authors:  Fangze Zhang; Rui Ding; Ping Li; Cuili Ma; Ding Song; Xuetong Wang; Tianjiao Ma; Liqi Bi
Journal:  Int J Clin Exp Med       Date:  2015-05-15

10.  Modulation of TNF-induced macrophage polarization by synovial fibroblasts.

Authors:  Laura T Donlin; Arundathi Jayatilleke; Eugenia G Giannopoulou; George D Kalliolias; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2014-07-23       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.